Scarica l'app Stockscreener
0.94
1.10%
0.03
Precedente Chiudi:
$0.91
Aprire:
$0.92
Volume 24 ore:
1,576
Relative Volume:
0.01
Capitalizzazione di mercato:
$14.18M
Reddito:
$321.50K
Utile/perdita netta:
$-7.24M
Rapporto P/E:
-0.5372
EPS:
-1.7498
Flusso di cassa netto:
$-5.72M
1 W Prestazione:
-3.16%
1M Prestazione:
-18.58%
6M Prestazione:
-57.60%
1 anno Prestazione:
-45.56%
Intervallo 1D:
$0.92
$0.9685
Intervallo di 1 settimana:
$0.833
$0.9685
Portata 52W:
$0.8305
$3.62
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Nome
Bioaffinity Technologies Inc
Settore
Industria
Telefono
210-698-5334
Indirizzo
22211 WEST INTERSTATE-10, SAN ANTONIO
Confronta BIAF con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
0.934 | 14.18M | 321.50K | -7.24M | -5.72M | -0.8398 |
|
TMO
Thermo Fisher Scientific Inc
|
522.29 | 198.99B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
231.00 | 165.80B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
134.87 | 38.37B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.82 | 35.67B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
417.16 | 33.85B | 3.84B | 866.24M | 792.60M | 10.37 |
Bioaffinity Technologies Inc Borsa (BIAF) Ultime notizie
**bioAffinity Technologies Reports Results of 2024 Special Meeting** - Defense World
bioAffinity Technologies (NASDAQ:BIAF) Shares Down 2% – Here’s Why - Defense World
bioAffinity Technologies Boosts Sales with CyPath Lung - Yahoo Finance
bioAffinity Technologies (NASDAQ:BIAFW) Trading Down 25.7% – Time to Sell? - Defense World
San Antonio biotech company looks to expand in 2025 - The Business Journals
bioAffinity Tech to Showcase Breakthrough Lung Cancer Detection Test in Exclusive Investor Webinar - StockTitan
Flow Cytometry in Oncology Market is Likely to Increase At - openPR
bioAffinity Technologies stock hits 52-week low at $0.91 By Investing.com - Investing.com UK
William Bauta to Spearhead Product Development at bioAffinity Technologies - MPO-mag
bioAffinity Technologies Set for Continued Expansion in 2025 - BioSpace
BioAffinity Technologies Set for Continued Expansion in 2025 - Marketscreener.com
bioAffinity's CyPath® Lung Test Drives Explosive 1,750% Sales Growth; Projects Strong 2024 Revenue - StockTitan
bioAffinity Technologies Adds Japanese Patent to its IP Portfolio - MPO-mag
bioAffinity Technologies stock hits 52-week low at $1.03 By Investing.com - Investing.com UK
Veterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply Schedule - Business Wire
bioAffinity's CyPath® Lung Cancer Test Secures Major Federal Access Through Veterans Health System - StockTitan
bioAffinity Technologies (NASDAQ:BIAFW) Stock Price Up 24.4% – Here’s What Happened - Defense World
BioAffinity Technologies files to sell 2.72M shares of common stock for holders - Nasdaq
bioAffinity Technologies stock hits 52-week low at $1.21 By Investing.com - Investing.com UK
BioAffinity Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Earnings roundup: Rackspace struggles as Victory Capital surges - San Antonio Express-News
bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024 - Zenopa
bioAffinity Technologies Reports Strong Q3 Growth - TipRanks
bioAffinity Technologies stock hits 52-week low at $1.24 By Investing.com - Investing.com Canada
bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development - Zenopa
bioAffinity appoints new Chief Science Officer By Investing.com - Investing.com Canada
bioAffinity appoints new Chief Science Officer - Investing.com India
bioAffinity Technologies Appoints William Bauta, Ph.D., as Chief Science Officer - citybiz
BioAffinity Technologies appoints William Bauta, Ph.D. Chief Science Officer - TipRanks
J. Michael Edwards Named CFO at bioAffinity Technologies - MPO-mag
SA company sets the stage for Asian expansion - The Business Journals
bioAffinity’s CyPath Lung Test Now Available to U.S. Veterans - MPO-mag
bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung - Zenopa
bioAffinity secures Japanese patent for lung health test By Investing.com - Investing.com South Africa
BIAFbioAffinity Technologies, Inc. Latest Stock News & Market Updates - StockTitan
bioAffinity secures Japanese patent for lung health test - Investing.com
bioAffinity Technologies Closes of $2.6 Million Registered Direct Offering & Concurrent Private Placement - citybiz
WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private Placement - StockTitan
bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement - StockTitan
SEC Form 424B5 filed by bioAffinity Technologies Inc. - Quantisnow
WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private Placement - StockTitan
bioAffinity Technologies Prices of $2.66 Million Registered Direct Offering & Concurrent Private Placement - citybiz
BioAffinity Technologies Down 25% on Stock Sale, Warrant Private Placement - MarketWatch
bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement - StockTitan
bioAffinity VP contributes to new cytometry guidelines - Investing.com
bioAffinity VP contributes to new cytometry guidelines By Investing.com - Investing.com South Africa
Bioaffinity Technologies Inc Azioni (BIAF) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.07%
0.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):